Allogene Therapeutics | ARS: Annual Report to Security Holders
Apr 23 16:38 ET
Allogene Therapeutics | POSASR: Post-effective amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
Mar 14 16:56 ET
Allogene Therapeutics | UPLOAD: Others
Feb 29 14:28 ET
Allogene Therapeutics | CORRESP: CORRESP
Feb 22 14:28 ET
Allogene Therapeutics | UPLOAD: Others
Dec 28, 2023 14:28 ET
Allogene Therapeutics | CORRESP: CORRESP
Dec 15, 2023 14:28 ET
Allogene Therapeutics | UPLOAD: Others
Nov 21, 2023 14:27 ET
Allogene Therapeutics | ARS: Annual Report to Security Holders
Apr 24, 2023 16:11 ET
Allogene Therapeutics | SC TO-I/A: Issuer tender offer statement (Amendment)
Jul 20, 2022 16:03 ET
Allogene Therapeutics | SC TO-I/A: Issuer tender offer statement (Amendment)
Jul 12, 2022 16:09 ET
Allogene Therapeutics | SC TO-I: Issuer tender offer statement
Jun 21, 2022 09:05 ET
Allogene Therapeutics | SC TO-C: Written communication relating to an issuer or third party tender offer
Apr 14, 2022 16:40 ET
Allogene Therapeutics | CT ORDER: Confidential Treatment Order
Oct 25, 2021 08:44 ET
Allogene Therapeutics | POS462B: Others
Oct 15, 2018 16:50 ET
Allogene Therapeutics | POS EX: Post-effective amendment filed solely to add exhibits to a registration statement
Oct 15, 2018 16:01 ET
Allogene Therapeutics | CERT: Others
Oct 10, 2018 10:23 ET
Allogene Therapeutics | CT ORDER: Confidential Treatment Order
Oct 10, 2018 07:16 ET
Allogene Therapeutics | CORRESP: CORRESP
Oct 4, 2018 21:16 ET
Allogene Therapeutics | CORRESP: CORRESP
Oct 4, 2018 21:13 ET
Allogene Therapeutics | CORRESP: CORRESP
Oct 2, 2018 09:34 ET
No Data
No Data